Research by Western Sydney University and the University of Newcastle, studying ten companies within the state, has considered the future of manufacturing and its role in addressing “challenges of growing inequality, social exclusion and environmental degradation.”
Two WA companies, First Graphene (ASX: FGR) and boot-maker Steel Blue, announced a 24-month supply agreement, with graphene additives to enhance an upcoming release of safety boots. This nanomaterial will be incorporated in boot components, including a thermoplastic polyurethane (TPU) sole. Graphene is a single layer of hexagonally-arranged carbon atoms, first successfully created in…
Pact Group (ASX:PGH) announced on Tuesday that it had appointed Citigroup to oversee the sale of its contract manufacturing division, which is worth an estimated $200 million.
Engineering skills underpin the functioning of our societies and economies. As we face the global challenges presented by a changing climate, food and water scarcity, loss of biodiversity and globalisation, these skills will only become more important.
Closed Loop held an event in Sydney on Monday to recycle its 10 millionth cup under the Simply Cups program.
Fuchs has announced that it will move production of Nulon automotive fluids to recently-upgraded sites at Beresfield, NSW and Sunshine, Victoria.
Former federal opposition leader Brendan Nelson will become president of Boeing Australia, New Zealand and South Pacific, effective February 11, replacing Maureen Dougherty in the role.
By Andrew Blakers, Professor of Engineering, Australian National University In the 1980s, a global race was underway: to find a more efficient way of converting energy from the sun into electricity. Some 30 years ago, our research team at the University of New South Wales (UNSW) came up with a breakthrough, called the PERC silicon…
Grants totalling $4.7 million and shared among nine companies under the federal Accelerating Commercialisation program have been announced.
A new Australian-made medical device, a balloon for drug delivery for atherosclerosis sufferers, is moving closer to commercialisation.
